C3 and viral infectious disease: The observation that these drugs also reduced syncytia formation are intriguing since they suggest that complement may also influences the biology of the virus in cells CD46, the receptor for C3b, the other major product of C3 processing, is known to enhance syncytia formation in other viral infections (43), so it is possible that reducing active C3 also reduces syncytia formation.